03/08/2013 - 5:18pm

Sales of glucose meters were slightly up over the holidays, reaching $67.7 million for the 12 weeks ended Dec. 30 across U.S. multi-outlets, according to SymphonyIRI Group data.

03/08/2013 - 5:18pm

Last year the Food and Drug Administration warned parents against using the ingredient benzocaine in children to relieve oral pain.

03/08/2013 - 5:18pm

With private label across analgesics up an estimated 11.3% to $1.7 billion, retailers are going to need to make some tough decisions as two internal analgesic powerhouses — McNeil's Tylenol and Novartis' Excedrin — make their way back onto market after respective recalls.

03/08/2013 - 5:18pm

Much of the policy-making conversation about health care in recent years has sought to highlight anticipated cost savings from technology innovation. Critics say this is an outgrowth of the American "fix-it" mentality. Others say technical solutions have yet to take hold outside of medical accounting applications. But there is general agreement that in the area of technologies to nurture medication adherence, the ground remains fertile.

02/28/2013 - 6:48pm

Has the explosion in generic utilization curbed pioneer-drug research and development? That's one concern floated by some pharmaceutical industry watchers, who claim that the stunning market share gains made by generic drug makers could reduce incentives for branded drug companies to spend to develop new molecular entities, conduct lengthy clinical trials, gain FDA approval and bring those new drugs to market.

02/28/2013 - 6:47pm

It's been long accepted that politics makes strange bedfellows. That's certainly the case with the reauthorization in 2012 of the Prescription Drug User Fee Act.

02/28/2013 - 6:47pm

Alabama's Supreme Court ruled in January that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

02/28/2013 - 6:47pm

Canadian generic drug makers expressed dismay over a new plan to reduce reimbursements for a half-dozen generic medications in most of the country's provinces. According to published reports, a group of premiers had reached a coordinated deal to reduce the prices their governments paid for six generic drugs, hoping to save the provinces nearly $100 million.

02/28/2013 - 6:47pm

Are doctors needlessly raising the costs of America's healthcare system through their prescribing habits? Absolutely, say researchers.